11-1257682-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002458.3(MUC5B):āc.16422G>Cā(p.Glu5474Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0291 in 1,570,458 control chromosomes in the GnomAD database, including 840 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_002458.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC5B | NM_002458.3 | c.16422G>C | p.Glu5474Asp | missense_variant | 41/49 | ENST00000529681.5 | NP_002449.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC5B | ENST00000529681.5 | c.16422G>C | p.Glu5474Asp | missense_variant | 41/49 | 5 | NM_002458.3 | ENSP00000436812.1 | ||
MUC5B | ENST00000526859.1 | c.57G>C | p.Glu19Asp | missense_variant | 1/6 | 3 | ENSP00000434539.1 |
Frequencies
GnomAD3 genomes AF: 0.0250 AC: 3807AN: 152216Hom.: 64 Cov.: 32
GnomAD3 exomes AF: 0.0231 AC: 4288AN: 185316Hom.: 67 AF XY: 0.0228 AC XY: 2310AN XY: 101466
GnomAD4 exome AF: 0.0296 AC: 41927AN: 1418124Hom.: 776 Cov.: 33 AF XY: 0.0289 AC XY: 20302AN XY: 703558
GnomAD4 genome AF: 0.0250 AC: 3806AN: 152334Hom.: 64 Cov.: 32 AF XY: 0.0254 AC XY: 1891AN XY: 74482
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Glu5474Asp in exon 41 of MUC5B: This variant is not expected to have clinical si gnificance because it has been identified in 3.0% (247/8246) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs56220864). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at